Harry McConnell

Unknown, Unknown · RMSANZ Member (Associate Membership) · FAFRM

Institution(s): AU

MM 1 - Metropolitan(Postcode: 4222)

Mental health and psychiatryGenetics and molecular biologyNeurorehabilitationSpinal cord injury rehabilitationEpidemiology and public health

H-index

Publications

1,339

Citations

5.25

FWCI

Funding Awards

Clinical Trials

Publication Timeline

Click a bar to filter publications by year

Clinical Trials (3)

A Novel Approach to Treatment Refractory Childhood Obsessive-Compulsive Disorder: D-Cycloserine Augmented Behaviour Therapy

ACTRN12609000370202Unknown

Novel Treatment of Phobias in Children and Teenagers

ACTRN12612000420842Unknown

Intensive treatment of Pediatric Obsessive Compulsive Disorder (OCD): Improving access and outcomes

ACTRN12614000140651Unknown

Funding Awards (34)

The neverending trip: Associations between Hallucinogen Persisting Perception Disorder (HPPD) and non-visual perceptual disturbances

Harvard University · 2025

The neverending trip: Associations between Hallucinogen Persisting Perception Disorder (HPPD) and non-visual perceptual disturbances

Macquarie University · 2025

Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial

National Health and Medical Research Council · 2022(APP1058025)

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

Howard Hughes Medical Institute · 2019

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

Burroughs Wellcome Fund · 2019

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

Brain and Behavior Research Foundation · 2019

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

Cancer Prevention and Research Institute of Texas · 2019

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

Fundación Alicia Koplowitz · 2019

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

Norges Idrettshøgskole · 2019

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

National Institutes of Health · 2019

Identifiers & Metadata

Profile ID:A5110073145

ORCID:0000-0002-5146-6973

Alt. IDs:

A5006680037 A5013408346 A5022124987 A5037296979 A5041639297

Confidence:HIGH

Collaborators:0

Verification:Round 2 CONFIRMED: database and ORCID names match 'Harry McConnell'. database shows AU affiliations and 52 works. Topics include neurology (epilepsy) and medical education, aligning with related medical fields. Status c

Publications (51 shown of 52 total)

Challenging history taking encounters: a systematic review, meta-analysis and phenomenological framework

BMJ Open · 2026 · 0 citations

The neverending trip: Associations between Hallucinogen Persisting Perception Disorder (HPPD) and non-visual perceptual disturbances

Journal of Psychedelic Studies · 2025 · 2 citations

3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception

Tuwhera (Auckland University of Technology) · 2025 · 0 citations● Rehab-relevant

Associations between Hallucinogen Persisting Perception Disorder (HPPD) and non-visual perceptual disturbances

PsyArXiv (OSF Preprints) · 2023 · 0 citations

Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial

Depression and Anxiety · 2022 · 20 citations

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis

Journal of Anxiety Disorders · 2019 · 54 citations

Sleep-Related Problems in Pediatric Obsessive-Compulsive Disorder and Intensive Exposure Therapy

Behavior Therapy · 2018 · 35 citations

D‐cycloserine‐augmented one‐session treatment of specific phobias in children and adolescents

Brain and Behavior · 2018 · 33 citations● Rehab-relevant

Integrated Care for NDIS Participants with Complex Needs

International Journal of Integrated Care · 2018 · 0 citations● Rehab-relevant

D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders

JAMA Psychiatry · 2017 · 285 citations